GSK’s Post

View organization page for GSK, graphic

4,110,774 followers

HIV remains one of the world’s biggest health epidemics, with 1.3 million new diagnoses annually, and more than 39 million people living with HIV. There is not yet a cure for HIV; however, 40 years of innovation has transformed HIV into a manageable, chronic health condition, enabling people living with HIV to lead long and healthy lives. Despite this progress, HIV stigma is still pervasive and impacts people living with HIV and their care. Our goal is to minimise the impact of HIV on people’s lives by treating and preventing the disease, and tackling HIV-related stigma. Find out more: https://gsk.to/3WFe2Le 👈 #AIDS2024

Glenny G. Hernandez

Cybernetic Medical Technology

2mo

Did I hear this right? “40 Years of innovation has transformed HIV into a manageable condition”. This is a hostage situation. Stemming from the gifting of infected measles blankets from the British to Native Indians that resulted in the death of 6 million Native Indians and then the death of 6 million Jews. Today, GSK sits on a vaccine with 100% efficacy and long term results against a Virus they started that today affects 4 Billion people in the world and they refuse to mass produce the vaccine. It most certainly is NOT called the Wuhan Virus. Lipid Coated viruses come from the British, they hold the cure, but prefer to monetize your misery. Here is a riddle. A) 1720 (Plague) = 1 B) 1820 (Cholera) = 1 C) 1920 (Spanish) = 1 D) 2020 (Corona) = 1 x 3 = 3 E) 2120 = 3 x 3 = 9 ? … https://Caluber.tech/aiaamd

A powerful reminder of the ongoing fight against HIV. 🌍 The progress made in treatment over 40 years is remarkable, yet tackling stigma remains crucial. Proud to see the efforts to improve lives and address these challenges.

Vassilis Doucas

Senior Research Investigator (Indépendant)

2mo

Innovation starts when we let innovation free from control.

Natanael Ortega Torres

Graduated - Bachelor Degree Natural Sciences

2mo

And don't be afraid to ask questions

See more comments

To view or add a comment, sign in

Explore topics